|
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
|
journal
|
October 2013 |
|
Slow Receptor Binding of the Noncytopathic HIV-2UC1 Envs Is Balanced by Long-Lived Activation State and Efficient Fusion Activity
|
journal
|
June 2020 |
|
Intra- and extra-cellular environments contribute to the fate of HIV-1 infection
|
journal
|
August 2021 |
|
T cell migration potentiates HIV infection by enhancing viral fusion and integration
|
journal
|
February 2022 |
|
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
|
journal
|
January 2019 |
|
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth
|
journal
|
November 2016 |
|
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
|
journal
|
May 2018 |
|
MiRNA-103 downmodulates CCR5 expression reducing human immunodeficiency virus type-1 entry and impacting latency establishment in CD4+ T cells
|
journal
|
October 2022 |
|
A Protocol for Studying HIV-1 Envelope Glycoprotein Function
|
journal
|
December 2020 |
|
Changes in the V1 Loop of HIV-1 Envelope Glycoproteins Can Allosterically Modulate the Trimer Association Domain and Reduce PGT145 Sensitivity
|
journal
|
May 2021 |
|
Indirect Mechanisms of HIV-1 Evasion from Broadly Neutralizing Antibodies In Vivo
|
journal
|
December 2022 |
|
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
|
journal
|
June 1998 |
|
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
|
journal
|
June 1996 |
|
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
|
journal
|
November 1996 |
|
Broad neutralization coverage of HIV by multiple highly potent antibodies
|
journal
|
September 2011 |
|
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
|
journal
|
September 2012 |
|
A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry
|
journal
|
August 2014 |
|
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
|
journal
|
June 2009 |
|
Capture of an early fusion-active conformation of HIV-1 gp41
|
journal
|
April 1998 |
|
The β20–β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions
|
journal
|
October 2017 |
|
Enhancing anti-viral neutralization response to immunization with HIV-1 envelope glycoprotein immunogens
|
journal
|
November 2023 |
|
Distinct viral reservoirs in individuals with spontaneous control of HIV-1
|
journal
|
August 2020 |
|
Strategies for an HIV cure: progress and challenges
|
journal
|
October 2018 |
|
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
|
journal
|
September 2018 |
|
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
|
journal
|
November 2016 |
|
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|
journal
|
March 2021 |
|
Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1
|
journal
|
November 2020 |
|
The Prefusogenic Intermediate of HIV-1 gp41 Contains Exposed C-peptide Regions
|
journal
|
February 2003 |
|
Conformation-Dependent Interactions Between HIV-1 Envelope Glycoproteins and Broadly Neutralizing Antibodies
|
journal
|
September 2018 |
|
CATNAP: a tool to compile, analyze and tally neutralizing antibody panels
|
journal
|
June 2015 |
|
Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study
|
journal
|
October 2010 |
|
Adjuvant‐mediated enhancement of the immune response to HIV vaccines
|
journal
|
March 2021 |
|
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
|
journal
|
September 2009 |
|
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|
journal
|
July 2010 |
|
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
|
journal
|
July 2010 |
|
Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions
|
journal
|
October 2014 |
|
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
|
journal
|
May 1996 |
|
CC CKR5: A RANTES, MIP-1 , MIP-1 Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
|
journal
|
June 1996 |
|
Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients
|
journal
|
May 1985 |
|
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
|
journal
|
December 2015 |
|
Multiple roles for HIV broadly neutralizing antibodies
|
journal
|
October 2019 |
|
SOSIP Changes Affect Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Conformation and CD4 Engagement
|
journal
|
July 2018 |
|
Loss of a Conserved N-Linked Glycosylation Site in the Simian Immunodeficiency Virus Envelope Glycoprotein V2 Region Enhances Macrophage Tropism by Increasing CD4-Independent Cell-to-Cell Transmission
|
journal
|
May 2014 |
|
Detecting Sources of Immune Activation and Viral Rebound in HIV Infection
|
journal
|
August 2022 |
|
Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins
|
journal
|
October 2016 |
|
Ultrasensitive quantification of HIV-1 cell-to-cell transmission in primary human CD4 + T cells measures viral sensitivity to broadly neutralizing antibodies
|
journal
|
January 2024 |
|
Conformation of HIV-1 Envelope Governs Rhesus CD4 Usage and Simian-Human Immunodeficiency Virus Replication
|
journal
|
February 2022 |
|
Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention
|
journal
|
April 2020 |
|
Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound
|
journal
|
May 2020 |
|
Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
|
journal
|
October 2010 |
|
An Inducible Cell-Cell Fusion System with Integrated Ability to Measure the Efficiency and Specificity of HIV-1 Entry Inhibitors
|
journal
|
November 2011 |
|
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection
|
journal
|
March 2016 |
|
SERINC5 Restricts HIV-1 Infectivity by Promoting Conformational Changes and Accelerating Functional Inactivation of Env
|
journal
|
June 2022 |
|
Antibodies and Lentiviruses That Specifically Recognize a T Cell Epitope Derived from HIV-1 Nef Protein and Presented by HLA-C
|
journal
|
December 2010 |